PTC-Guided Atorvastatin Plus Axitinib and Toripalimab in Advanced RCC
PTC-Guided Atorvastatin Plus Axitinib and Toripalimab in Advanced RCC
Not yet recruiting · NCT07630363 · Registry updated 2026-06-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| PTC-Guided Atorvastatin Plus Axitinib and Toripalimab in Advanced RCC | Advanced Renal Cell Carcinoma (RCC); Atorvastatin; PTC; Targeted Therapy Combined With Immunotherapy | Not yet recruiting | Phase 1 / Phase 2 | 2026-06-05 | NCT07630363 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 294 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, Beijing 101205 | Beijing | China | 1 |